Trials / Completed
CompletedNCT03024229
Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine
The Importance of Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine Before Renal Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
When the kidneys are perfused on perfusion machines before transplantation, the resistance parameters as well as the histological score on the pre-implantation biopsy participate in the evaluation of the quality of the graft. The metabolomic profile of the infusion fluid could provide additional evidence.
Detailed description
The quality of the renal transplant prior to transplantation is essential for the recovery of graft function in the days following transplantation and its long-term survival. When the kidneys are perfused on perfusion machines before transplantation, the resistance parameters as well as the histological score on the pre-implantation biopsy participate in the evaluation of the quality of the graft. The metabolomic profile of the infusion fluid could provide additional evidence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LifePort® perfusion machine | Renal perfusion on LifePort® machine |
Timeline
- Start date
- 2017-03-15
- Primary completion
- 2019-09-15
- Completion
- 2020-01-14
- First posted
- 2017-01-18
- Last updated
- 2025-12-23
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03024229. Inclusion in this directory is not an endorsement.